FABHALTA

This brand name is authorized in United States

Active ingredients

The drug FABHALTA contains one active pharmaceutical ingredient (API):

1 Iptacopan UNII 8E05T07Z6W - IPTACOPAN

Iptacopan binds to Factor B of the alternative complement pathway and regulates the cleavage of C3, generation of downstream effectors, and the amplification of the terminal pathway. Read about Iptacopan

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FABHALTA Capsule	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AJ08		L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AJ Complement inhibitors
Discover more medicines within L04AJ08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 0078-1189